Brokers say these 3 ASX 200 blue-chip shares are buys in December

Want some blue chips? Then check out these buy-rated shares

| More on:
Three people in a corporate office pour over a tablet, ready to invest.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're looking to add some ASX 200 blue-chip shares to your portfolio in December, then the three listed below could be worth considering.

These ASX 200 shares have all been named as buys by brokers recently. Here's what you need to know about them:

Endeavour Group Ltd (ASX: EDV)

Goldman Sachs thinks that Endeavour is an ASX 200 blue chip share to buy. It is the drinks giant behind the BWS and Dan Murphy's brands, as well as a huge network of hotels.

The broker believes that the company's shares are cheap based on its market leadership and positive outlook. It said:

Most attractive valuation amongst Staples peers: We continue to see defensiveness in the company's Retail business with relative market share of ~35% vs COL liquor of ~13%, 5.2mn active My Dan's members. EDV is currently trading at FY24e P/E of 18.4x with FY23-25e EPS CAGR of ~5%, which is the cheapest vs WOW, COL, WES.

Goldman has a conviction buy rating and a $6.40 price target on the company's shares.

Macquarie Group Ltd (ASX: MQG)

Another ASX 200 blue-chip share that could be a buy is Macquarie.

Morgans likes the investment bank for a number of reasons. This includes its exposure to long-term structural growth. The broker explains:

We continue to like MQG's exposure to long-term structural growth areas such as infrastructure and renewables. The company also stands to benefit from recent market volatility through its trading businesses, while it continues to gain market share in Australian mortgages.

Morgans has an add rating and a $182.80 price target on its shares.

ResMed Inc. (ASX: RMD)

A final ASX 200 blue-chip share that has been named as buy is ResMed. It is a sleep treatment-focused medical device company with a portfolio of leading hardware and digital solutions.

Goldman Sachs is also positive on the company and believes recent share price weakness has created a buying opportunity. It said:

We view the risk/reward to be favorable and are Buy-rated. We view valuation as attractive and see a favourable risk-reward skew post the recent de-rate, noting the shares are trading meaningfully below historical averages on both a P/E and EV/EBITDA basis.

Goldman has a buy rating and a $32 price target on the company's shares.

Motley Fool contributor James Mickleboro has positions in Endeavour Group and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Macquarie Group, and ResMed. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Blue Chip Shares

Why brokers say these ASX 200 blue-chip shares are strong buys

These blue chips could have plenty of upside according to brokers.

Read more »

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Blue Chip Shares

Forget CBA and buy these ASX shares

Analysts prefer these shares over Australia's largest bank.

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Blue Chip Shares

2 high-quality ASX shares to buy after the market sell-off

Could this market sell-off be a buying opportunity for investors? Here are two shares analysts rate as buys.

Read more »

a man looks down at his phone with a look of happy surprise on his face as though he is thrilled with good news.
Blue Chip Shares

2 of the best ASX 200 blue-chip shares to buy now

Analysts think these blue chips could be best buys this month.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Blue Chip Shares

These ASX 200 shares could rise 25% to 35%

Analysts believe these shares could rise strongly from current levels.

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

4 ASX 200 blue chip shares to buy now

Analysts say these high-quality companies are top buys in April.

Read more »

Confident male executive dressed in a dark blue suit leans against a doorway with his arms crossed in the corporate office
Blue Chip Shares

Why I'd confidently buy these 3 ASX blue-chips while others grow fearful

As legendary investor Warren Buffett famously advises, “Be greedy when others are fearful.”

Read more »

Seven men and women of different ages and nationalities put their heads together and smile as they look down at the camera.
Blue Chip Shares

2 ASX shares I'd buy to quickly add diversification

I like these stocks for Aussies wanting different blue-chip exposure.

Read more »